SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securities Laws by the Board of Directors of Fresenius Medical Care AG & Co. KGAA

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky, LLP is investigating Fresenius Medical Care AG & Co. KGAA ("Fresenius Medical" or the "Company") FMS in connection with possible breaches of federal securities laws.

To get more information, click here: http://zlk.9nl.com/fresenius-fms. There is no cost or obligation to you.

On January 6, 2017, the Wall Street Journal published an article disclosing that Fresenius Medical's North American subsidiary unit had received subpoenas from federal prosecutors seeking information on the Company's ties with the American Kidney Fund, a charity that helps patients pay for kidney dialysis. On this news, shares of Fresenius have fallen approximately 7% during intraday trading on January 9, 2017.

If you own common stock in Fresenius Medical and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/fresenius-fms.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170126006266/en/